Trademark: 79191669
Status Date
Tuesday, July 11, 2017
Registration Number
5238680
Registration Date
Tuesday, July 11, 2017
Filing Date
Monday, April 25, 2016
Published for Opposition
Tuesday, April 25, 2017
5 Antibodies, antibody fragments and antigens in the nature of pharmaceuticals for the treatment of cancer, haematopoietic diseases, autoimmune diseases, neurodegenerative diseases, metabolic diseases, eye diseases, infections, diseases of heart and circulation, bone diseases, transplantation, sepsis, intoxications, and adverse drug reactions
1 [ Monoclonal antibodies for quantitative determination of leukocyte subsets other than for medical purposes; chemicals components being biochemicals for producing radio-labelled monoclonal antibodies for industrial or scientific purposes; proteins for detecting antibodies other than for medical purposes; ] monoclonal antibodies for industrial use; monoclonal antibody reagents, other than for medical use; antigens and antibodies being biochemicals for diagnostic use not for medical purposes; immunological antibodies, being biochemicals, other than for medical use; tagged antibodies being biochemicals for scientific use; [ monoclonal antibodies for qualitative determination of leukocyte subsets other than for medical purposes; linkage compounds being biochemicals for scientific purposes for coupling of radioactive compounds to antibodies; reagents for use in the development of hybridoma antibodies other than for medical or veterinary purposes; ] biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; proteins for binding antibodies other than for medical purposes; monoclonal antibodies for scientific use; [ linkage compounds being biochemicals for scientific purposes for coupling antibodies to radio nuclides; monoclonal antibodies for research into haematopoietic systems other than for medical purposes; ] reagents for use in development of monoclonal antibodies other than for medical or veterinary purposes; [ components for producing radio-labelled antibody fragments for industrial or scientific purposes being biochemicals; ] tagged antibodies being biochemicals for laboratory use; reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) other than for medical or veterinary purposes comprised primarily of biochemicals
42 Scientific research; technological services being antibody engineering and design; industrial analysis and research services in the nature of laboratory research and new product design services relating to the production of monoclonal antibodies
Apr 3, 2024
Post Registration Action Mailed - Sec. 71 & 15
Mar 25, 2024
Case Assigned To Post Registration Paralegal
Jul 10, 2023
Teas Section 71 & 15 Received
Feb 18, 2023
New Representative At Ib Received
Aug 15, 2019
Change Of Name/Address Rec'd From Ib
Nov 10, 2017
Final Decision Transaction Processed By Ib
Oct 20, 2017
Final Disposition Notice Sent To Ib
Oct 20, 2017
Final Disposition Processed
Oct 11, 2017
Final Disposition Notice Created, To Be Sent To Ib
Jul 11, 2017
Registered-Principal Register
Apr 25, 2017
Published For Opposition
Apr 22, 2017
Notification Processed By Ib
Apr 21, 2017
Assigned To Examiner
Apr 5, 2017
Notification Of Possible Opposition Sent To Ib
Apr 5, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 5, 2017
Notice Of Publication
Mar 20, 2017
Examiners Amendment Mailed
Mar 18, 2017
Approved For Pub - Principal Register
Mar 18, 2017
Examiner's Amendment Entered
Mar 18, 2017
Examiners Amendment -Written
Oct 16, 2016
Refusal Processed By Ib
Sep 28, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Sep 28, 2016
Refusal Processed By Mpu
Sep 27, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Sep 26, 2016
Non-Final Action Written
Sep 20, 2016
Application Filing Receipt Mailed
Sep 16, 2016
Assigned To Examiner
Sep 16, 2016
New Application Office Supplied Data Entered
Sep 15, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
